Enteral lorlatinib after alectinib as a treatment option in anaplastic lymphoma kinase-positive non-small cell lung cancer with triple problems: carcinomatous meningitis, poor performance status, and dysphagia-a case report.

Sasaki, Kota; Yokota, Yusuke; Isojima, Toshihito; Fujii, Mayumi; Hasui, Kengo; Chen, Yu; Saito, Kensuke; Takahata, Takenori; Kindaichi, Seiko; Sato, Atsushi

Sasaki, Kota; Yokota, Yusuke; Isojima, Toshihito; Fujii, Mayumi; Hasui, Kengo; Chen, Yu; Saito, Kensuke; Takahata, Takenori; Kindaichi, Seiko; Sato, Atsushi.

Afiliación

Sasaki K; Department of Medical Oncology Hirosaki University Graduate School of Medicine Aomori Japan.
Yokota Y; Department of Internal medicine Aomori Kyoritsu Hospital Aomori Japan.
Isojima T; Department of Internal medicine Aomori Kyoritsu Hospital Aomori Japan.
Fujii M; Department of Internal medicine Aomori Kyoritsu Hospital Aomori Japan.
Hasui K; Department of Pharmacy Aomori Kyoritsu Hospital Aomori Japan.
Chen Y; Department of Medical Oncology Hirosaki University Graduate School of Medicine Aomori Japan.
Saito K; Department of Medical Oncology Hirosaki University Graduate School of Medicine Aomori Japan.
Takahata T; Department of Medical Oncology Hirosaki University Graduate School of Medicine Aomori Japan.
Kindaichi S; Department of Medical Oncology Hirosaki University Graduate School of Medicine Aomori Japan.
Sato A; Department of Pharmacy Aomori Kyoritsu Hospital Aomori Japan.

Respirol Case Rep ; 9(7): e00796, 2021 Jul.

Article en En | MEDLINE | ID: mdl-34123384

Palabras clave

ALK inhibitor; brain metastasis; comatose; nasogastric tube; simple suspension method

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Respirol Case Rep Año: 2021 Tipo del documento: Article